JAC Advance Access originally published online on August 5, 2006
Journal of Antimicrobial Chemotherapy 2006 58(4):896; doi:10.1093/jac/dkl296
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author 2006. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org
Correspondence |
Comment on: Guidelines for the prevention of endocarditis: report of the Working Party of the British Society for Antimicrobial Chemotherapy
1 President, British Congenital Cardiac Association, Department of Congenital Heart Disease E Floor Jubilee Wing, Leeds General Infirmary, Leeds LS1 3EX, UK 2 Chairman, Clinical Practice Committee of the British Cardiovascular Society 9 Fitzroy Square, London W1T 5HW, UK 3 President, British Cardiovascular Society 9 Fitzroy Square, London W1T 5HW, UK
*Corresponding author. Tel: +44-113-392-5757; Fax: +44-113-392-5750; E-mail: jgibbs@boltblue.com
Keywords: primary care , antibiotic policy , endocarditis
| The first 10% of the full text of this article appears below. |
Sir,
Neither the British Congenital Cardiac Association (BCCA) nor the British Cardiovascular Society (BCS) agree with the new guidelines for the prevention of endocarditis published by the British Society for Antimicrobial Chemotherapy (BSAC) Endocarditis Working Party.1
Transparency declarations
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
P. P. Gopalakrishnan, S. K. Shukla, and T. Tak Infective Endocarditis: Rationale for Revised Guidelines for Antibiotic Prophylaxis Clin. Med. Res., September 1, 2009; 7(3): 63 - 68. [Full Text] [PDF] |
||||
